KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
VN Biolabs: 8 Kovera certificates.
The lab's record shows 8 certificates printed for VN Biolabs, analysed between 4 Mar 2026 and 4 Mar 2026, covering 7 products. Median HPLC purity is 99.96%. Kovera graded 8 as a pass and 0 as a fail.
8
certificates
99.96%
median purity
7
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 8 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 3 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
7 AS PRINTEDRetatrutide · 2CJC-1295 (No DAC)/Ipamorelin · 1DSIP · 1GHK-Cu · 1Klow · 1Melanotan-2 · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 8 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-F1B44E | GHK-Cu | VN-0326-01 | 99.974% | 110.3%110.27 of 100 mg | 4 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BA0B90 | Retatrutide | VN-0326-01 | 99.921% | 105.4%21.08 of 20 mg | 4 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8D281F | Retatrutide | VN-0326-01 | 99.976% | 107.2%10.72 of 10 mg | 4 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-42B4C2 | CJC-1295 (No DAC)/Ipamorelin | VN-0326-01 | 99.916% | 111.4%11.14 of 10 mg | 4 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-40C11D | Tirzepatide | VN-0326-01 | 99.978% | 107.5%32.24 of 30 mg | 4 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1F50EF | Melanotan-2 | VN-0326-01 | 99.986% | 129.4%12.94 of 10 mg | 4 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1AFA94 | Klow | VN-0326-01 | 99.514% | 108.7%86.96 of 80 mg | 4 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1762E2 | DSIP | VN-0326-01 | 99.938% | 107.6%16.14 of 15 mg | 4 Mar 2026 | PASS | Kovera ↗our verifier → |